Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy

Predictors of response to reinduction ch

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy

✍ Joseph M. Brandwein; Vikas Gupta; Andre C. Schuh; Aaron D. Schimmer; Karen Yee; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

## Abstract Eighty‐one patients with acute myeloid leukemia who had persistent leukemia following standard induction therapy with cytarabine plus daunorubicin (7+3 regimen) underwent reinduction therapy with a combination of mitoxantrone, etoposide, and high‐dose cytarabine (HiDAC). Patients achiev